Member Info for teraferma

Starting to look pretty serious for the UK poultry industry .

https://www.fwi.co.uk/livestock/poultry/layers/over-a-million-layers-to-be-culled-as-bird-flu-strikes-indoor-flock

We're proud to announce the successful completion of a clinical trial in Ethiopia for our groundbreaking saliva-based HIV rapid test!

https://newsdirect.com/news/salignostics-advances-saliva-based-hiv-testing-with-successful-clinical-trial-in-ethiopia-735106567

Trading pattern continues.

As soon as the price starts getting a bit of traction it gets hammered down with large(ish) sells.

Either we have a large seller here or price is being deliberately subdued.

I hoping for revenue for H1 around £4.5-5M up from £2.4M from H1 23.

This would include organic growth through the acquisitions of IDVeology (approx rev £220K) and Compliance solutions (£1.4M)

I am hoping the amalgamation of the three companies will reduce headcount and admin costs, so hoping to be EBITA positive (despite some one off costs) with a small loss for the period, but hopefully setting the company up for a decent H2.

Yeah fair point, maybe EV would be a better metric.

Agree with all you’ve stated Muck

But you really need to compare MCAPs for the periods.

£13M in Jan now £14M

The large dilution has obviously stagnated the SP but for me it’s short term pain for long term higher growth and subsequently higher profitability.

At least this is the management plan.

Also the new US analytical and manufacturing base will surely help with the FDA approval process and possibly put Abingdon in line for a US distribution deal with Salignostics, which would be huge.

Our laboratory site in the US will mean we can offer US customers the opportunity to buy their services in the US; this is a first step for Abingdon to provide a broader [contract development & manufacturing organisation] proposition from within the US market."

Https://www.linkedin.com/posts/salignostics_this-startup-is-on-a-mission-to-redefine-activity-7274786713820880897-yKXy?utm_source=share&utm_medium=member_ios

Interesting post from Candice

At Abingdon Health, we're all about making rapid tests accessible to everyone. The FDA's increased adoption of rapid home tests supports our mission by highlighting the importance of accessible, reliable testing solutions. This regulatory backing helps us innovate and bring high-quality rapid tests to more people, ensuring everyone has the ability to manage their health more effectively.

I'm particularly excited about how our new laboratory and office in Madison USA is enhancing our capabilities and reach. The FDA's support for rapid home testing aligns perfectly with our expansion, enabling us to leverage local resources and talent to accelerate our mission. This synergy is helping us bring innovative testing solutions to a broader audience more efficiently.

https://www.linkedin.com/posts/candice-vendettuoli-51b9b31a1_fda-lateralflow-hometesting-activity-7271618907000475650-xZ2H?utm_source=share&utm_medium=member_ios

Thrilled to share that our RADAR study results are being presented today at the UK Stroke Forum! 🎉

This study explored our innovative LVONE test for LVO stroke diagnosis, demonstrating its potential to revolutionise early patient identification for emergency clinicians 🚑

We're incredibly proud of this achievement, culminating a 2-year project funded by SBRI Healthcare. Huge Thanks to Newcastle University for organising and running the study 🔬

Key Findings:

💥LVONE is more accurate than current practice for LVO diagnosis

💥LVONE effectively rules out patients without the condition, avoiding hospital overload

🚀 Next Up? Initiate pilot studies within the NHS. Let's continue to push the boundaries of stroke care together!

https://www.linkedin.com/posts/edo-gaude-02283945_stroke-healthcare-innovation-activity-7270378444666937344-KzSh?utm_source=share&utm_medium=member_ios

Yes huge news especially this part and also the comments from the cEO..

"The deal marks the first instance of an investment being co-led by leading hospital ventures funds from both the UK and the US, underlining 52North’s positioning as a healthcare innovator for global impact."

Umaima Malik Ahmad CEO & Co-Founder, 52North

"A brilliant way to wrap up a solid year of hard work to deliver better and safer care to patients - though of course... we're not quite done yet with news for the year. Are we ever? 😉"

We're delighted to announce $6m in new funding, including a landmark first ever investment deal to be co-led by funds linked to both US and UK hospitals, KHP Ventures and Cedars-Sinai, and a $1.5m grant from NIHR (National Institute for Health and Care Research).

https://52north.health/news/52north-secures-6m-with-landmark-uk-us-hospital-vc-deal?

There’s the buyer 250k @ 7.5p

STFL have now flipped and are bidding for 500K @ 7.12, looks strong

All smoke and mirrors here but bodes well

Spread 7.12-7.34

There's still a bit of stock sub 7.5p to shift, but nice to see 7.27 gone

Book firmed this morning but STFL keep moving on/off the ASK so hard to tell.

Spread is now 7.08 - 7.40

Spread has been the same all week (not the same as the advertised spread)

That’s an MM trick to give the impression of selling.

More buys at 7.24p than sells on Friday

If you have access to the RSP you can see the real prices.

Someone’s absorbing the sells.

After a poorly handled raise IMO, I am calling a bottom here.

Got burnt in the last raise at 25p so decided not to take part this time.

I think we have a buyer around the 7p level, yet to be revealed.

Looking to add once the remaining sub 7.5p stock goes.

Chris Yates in India as part of the UK Govt Healthcare trade mission.

https://www.linkedin.com/posts/activity-7267238928963756035-cc3P?utm_source=share&utm_medium=member_desktop

HyProMag USA BFS is due end of year, confirmed all on track on the latest CoTec upgrade.

This will blow Ionic out of the water, lower CAPEX, lower OPEX and initially funding requirements will be a lot less than the £80M Ionic require.

We've had Tom Albanese (Cotec director)do a pretty bullish interview recently https://t.co/JHJpe9dhYb

Also worth listening to Julian Treger in this interview last week.. From 46 mins in https://t.co/SO81GvKhYI

confirming they are speaking to multinational companies, Apple, Microsoft, Ebay, Tesla ......

They ain't talking about Iron pellets that for sure.

Mkango have previously said they expect to have nearly 10000 finished magnets by EOY

Share price following a similar pattern to last year.

We had a sell off post year end results in October, followed by director buys a week later.

Also the last interview ABDX marked the lows of March 24.

Lets see what happens here.

anyone have access to the zeus broker note?

https://*********************/companies/uk/medical-equipment-services/abingdon-health-plc/research/zeus-capital/abingdon-health-abdx-ln-strong-fy-2024-and-primed-for-expansion/c7422282-9d11-4d20-beca-6d8cf927660c